[go: up one dir, main page]

ES534195A0 - Procedimiento para preparar una solucion estable de proteina - Google Patents

Procedimiento para preparar una solucion estable de proteina

Info

Publication number
ES534195A0
ES534195A0 ES534195A ES534195A ES534195A0 ES 534195 A0 ES534195 A0 ES 534195A0 ES 534195 A ES534195 A ES 534195A ES 534195 A ES534195 A ES 534195A ES 534195 A0 ES534195 A0 ES 534195A0
Authority
ES
Spain
Prior art keywords
formula
preparing
procedure
hydrogen
protein solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES534195A
Other languages
English (en)
Other versions
ES8600319A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES534195A0 publication Critical patent/ES534195A0/es
Publication of ES8600319A1 publication Critical patent/ES8600319A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
ES534195A 1983-07-13 1984-07-11 Procedimiento para preparar una solucion estable de proteina Expired ES8600319A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833325223 DE3325223A1 (de) 1983-07-13 1983-07-13 Gegen denaturierung bestaendige, waessrige proteinloesungen, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
ES534195A0 true ES534195A0 (es) 1985-10-01
ES8600319A1 ES8600319A1 (es) 1985-10-01

Family

ID=6203842

Family Applications (2)

Application Number Title Priority Date Filing Date
ES534195A Expired ES8600319A1 (es) 1983-07-13 1984-07-11 Procedimiento para preparar una solucion estable de proteina
ES535482A Expired ES8609361A1 (es) 1983-07-13 1984-08-29 Procedimiento para tratar superficies hidrofobas para la supresion de su efecto adsorbente y desnaturalizante sobre proteinas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES535482A Expired ES8609361A1 (es) 1983-07-13 1984-08-29 Procedimiento para tratar superficies hidrofobas para la supresion de su efecto adsorbente y desnaturalizante sobre proteinas

Country Status (15)

Country Link
US (1) US4637834A (es)
EP (1) EP0131864B1 (es)
JP (1) JPS6038398A (es)
KR (1) KR920002934B1 (es)
AT (1) ATE56876T1 (es)
AU (1) AU579106B2 (es)
DE (2) DE3325223A1 (es)
DK (1) DK168030B1 (es)
ES (2) ES8600319A1 (es)
FI (1) FI80276C (es)
GR (1) GR81504B (es)
IE (1) IE57694B1 (es)
IL (1) IL72389A (es)
PT (1) PT78892A (es)
ZA (1) ZA845384B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0018609B1 (de) * 1979-04-30 1983-09-21 Hoechst Aktiengesellschaft Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung
JPS61277633A (ja) * 1985-05-31 1986-12-08 Toray Ind Inc インタ−フエロン組成物
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
US4956274A (en) * 1987-04-06 1990-09-11 Microgenics Corporation Reagent stabilization in enzyme-donor and acceptor assay
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
US5830452A (en) * 1990-11-20 1998-11-03 Chiron Corporation Method for enhancing the anti-tumor therapeutic index of interleukin-2
JPH08502021A (ja) * 1992-04-07 1996-03-05 マリンクロッド・ヴェタラネリィ・インコーポレイテッド 生体相容性ソマトトロピン溶液
ATE359824T1 (de) * 1992-07-31 2007-05-15 Genentech Inc Wässrige formulierung enthaltend menschliches wachstumshormon
ATE358684T1 (de) * 1995-06-07 2007-04-15 Novartis Vaccines & Diagnostic Waessrige formulierung enthaltend tfpi und lösungsvermittlers
US6790439B1 (en) 1995-06-07 2004-09-14 Zymogenetics, Inc. Thrombopoietin compositions
MX9602398A (es) * 1995-06-23 1997-02-28 Kimberly Clark Co Material polimerico modificado teniendo humectabilidad mejorada.
AUPN801296A0 (en) * 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
PL353238A1 (en) * 1999-07-12 2003-11-03 Grandis Biotech Gmbh Growth hormone formulations
AU2003250915A1 (en) * 2002-07-09 2004-01-23 Sandoz Ag LIQUID FORMULATIONS WITH HIGH CONCENTRATION OF HUMAN GROWTH HORMONE (hgh) COMPRISING 1,2-PROLPYLENE GLYCOL
US7851433B2 (en) * 2003-08-13 2010-12-14 Novartis Vaccines And Diagnostics, Inc. Method of purifying TFPI and TFPI analogs
MXPA06011029A (es) 2004-04-07 2007-01-25 Ares Trading Sa Formulacion liquida de hormona del crecimiento.
EP1847830A1 (en) * 2006-04-20 2007-10-24 TF Instruments, Inc. Determining optimal concentrations of protective additives for biomolecules
WO2024133849A1 (en) * 2022-12-22 2024-06-27 The Protein Brewery B.V. Ovalbumin fermentation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439355A (en) * 1976-12-02 1984-03-27 Colgate-Palmolive Company Elastic detergent product of improved foaming power after use
DE2917535C2 (de) * 1979-04-30 1986-10-30 Hoechst Ag, 6230 Frankfurt Gegen Denaturierung beständige Insulinlösungen
EP0018609B1 (de) * 1979-04-30 1983-09-21 Hoechst Aktiengesellschaft Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung
JPS58501125A (ja) * 1981-07-17 1983-07-14 ノルデイスク・インスリンラボラトリウム 安定な水性治療性インシユリン製剤及びその製造方法

Also Published As

Publication number Publication date
DE3483287D1 (de) 1990-10-31
US4637834A (en) 1987-01-20
KR920002934B1 (ko) 1992-04-10
JPS6038398A (ja) 1985-02-27
ES8600319A1 (es) 1985-10-01
DK168030B1 (da) 1994-01-24
FI842798A0 (fi) 1984-07-11
IE57694B1 (en) 1993-03-10
PT78892A (de) 1984-08-01
ZA845384B (en) 1985-02-27
ES535482A0 (es) 1986-09-01
AU579106B2 (en) 1988-11-17
IL72389A0 (en) 1984-11-30
EP0131864B1 (de) 1990-09-26
DK342684D0 (da) 1984-07-12
FI80276C (fi) 1990-05-10
AU3053784A (en) 1985-01-17
JPH0582397B2 (es) 1993-11-18
GR81504B (es) 1984-12-11
KR850000971A (ko) 1985-03-14
ES8609361A1 (es) 1986-09-01
DK342684A (da) 1985-01-14
IE841796L (en) 1985-01-13
DE3325223A1 (de) 1985-01-24
FI842798A (fi) 1985-01-14
ATE56876T1 (de) 1990-10-15
EP0131864A2 (de) 1985-01-23
IL72389A (en) 1988-11-30
EP0131864A3 (en) 1987-08-26
FI80276B (fi) 1990-01-31

Similar Documents

Publication Publication Date Title
ES534195A0 (es) Procedimiento para preparar una solucion estable de proteina
MX9203406A (es) Azolilmetiloxiranos y su uso como agentes protectores de cosechas.
ES2060594T3 (es) Proceso para purificar proteinas recombinantes y uso de productos de las mismas.
DK520784A (da) Cycliske polypeptider, deres fremstilling og anvendelse
NZ220546A (en) Benzothiophene- and benzofuran- amides and compositions
PT90572A (pt) Processo para a preparacao de derivados de 6-fenil-3-piperazinilalquil-1h,3h-2,4-pirimidinadiona
NO895002D0 (no) Enzymhemmende aminosyrederivater.
AU1779188A (en) Guanidine-related compounds comprising a substituted tetraphenylborate ion, process for obtaining these compounds, and use of the compounds
PT90814A (pt) Processo de preparacao de derivados da fenotiazina
NO169176C (no) Tyroninderivater, og deres fremstillig og anvendelse
ATE111894T1 (de) Verfahren zur herstellung von clausenamid und neoclausenamid und deren derivate.
ES504259A0 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina
DK242089A (da) Anvendelse af pyrimido oe6,1-aaa-isoquinolin-4-on-derivater til hindring af haaraffald og foroegelse af haarvaekst
ES2043784T3 (es) Procedimiento de preparacion de compuestos guanidinicos.
EA199900710A1 (ru) Кристаллическая гидратированная натриевая соль (е)-4,6-дихлор-3-(2-оксо-1-фенилпирролидин-3-илиденметил)-1н-индол-2-карбоновой кислоты
EA199900723A1 (ru) Производные феноксиуксусной кислоты и их применение в качестве гербицидов
ATE111087T1 (de) Verfahren zur herstellung von 2-aryl-2h-1,2,3- triazolen.
DK256384A (da) Beta-carbolin-3-carboxylsyrederivater
IT1265314B1 (it) Acilsulfammidi ad attivita' antitumorale

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050618